Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Leslie A. Parsels

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5880-1033; OpenAlex author ID A5065044290; NIH RePORTER profile ID 10783549. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
1
Labs led
1
Collaborators
26
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 grant

Papers 10

  1. Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-24-0210↗
  2. Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer. Co-author DOI 10.1172/jci.insight.168824↗
  3. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-21-0725↗
  4. Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-20-0365↗
  5. Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy. Co-author DOI 10.1158/0008-5472.can-19-0761↗
  6. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic C… Co-author DOI 10.1200/jco.19.00730↗
  7. Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-1038↗
  8. Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776. First author DOI 10.1158/1078-0432.ccr-12-3748↗
  9. Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. First author DOI 10.1593/neo.12538↗
  10. Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1. Co-author DOI 10.4161/cc.10.24.18661↗

Grants 1

  1. Improving the efficacy of radiotherapy by targeting the DNA damage response, tumor immunology and tumor metabolism R50CA251960↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Theodore Steven Lawrence · 10 shared papers, 2011–2025 · strength 0.90
  2. Meredith Ann Morgan · 10 shared papers, 2011–2025 · strength 0.90
  3. Qiang Zhang · 3 shared papers, 2022–2025 · strength 0.49
  4. Vaibhav Sahai · 3 shared papers, 2019–2025 · strength 0.44
  5. David M. Karnak · 4 shared papers, 2013–2025 · strength 0.39
  6. Victoria M. Valvo · 2 shared papers, 2024–2025 · strength 0.35
  7. Timothy L. Frankel · 2 shared papers, 2019–2022 · strength 0.21
  8. Jonathan Maybaum · 5 shared papers, 2011–2019 · strength 0.21
  9. Qiang Zhang · 2 shared papers, 2019–2021 · strength 0.21
  10. Carl G. Engelke · 3 shared papers, 2013–2021 · strength 0.20
  11. Alnawaz Rehemtulla · 1 shared paper, 2025 · strength 0.18
  12. Eileen S. Carpenter · 1 shared paper, 2025 · strength 0.18
  13. Matthew T. McMillan · 1 shared paper, 2022 · strength 0.13
  14. Weiwei Wang · 1 shared paper, 2022 · strength 0.13
  15. Hari Nathan · 1 shared paper, 2019 · strength 0.08
  16. Clifford S. Cho · 1 shared paper, 2019 · strength 0.08
  17. Mark M. Zalupski · 1 shared paper, 2019 · strength 0.08
  18. Kyle Clifford Cuneo · 1 shared paper, 2019 · strength 0.08
  19. Marina Pasca di Magliano · 1 shared paper, 2019 · strength 0.08
  20. Jiaqi Shi · 1 shared paper, 2019 · strength 0.08
  21. Dongping Wei · 2 shared papers, 2013–2014 · strength 0.07
  22. Venkatasubbaiah A. Venkatesha · 1 shared paper, 2012 · strength 0.03
  23. Diane M. Simeone · 1 shared paper, 2012 · strength 0.03
  24. Qiang Zhang · 1 shared paper, 2013 · strength 0.03
  25. Sean M. Vance · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.